GETEIN BIOTECH, INC Getein Biotech, Inc Share Price
Equities
603387
CNE100002RR9
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.04 CNY | +0.44% |
|
+4.75% | -17.82% |
| 2023 | Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| 2023 | Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| Sales 2021 | 1.4B 193M 16.13B | Sales 2022 | 1.82B 251M 20.96B | Capitalization | 6.34B 875M 72.95B |
|---|---|---|---|---|---|
| Net income 2021 | 399M 55.07M 4.59B | Net income 2022 | 499M 68.87M 5.74B | EV / Sales 2021 | 4.4 x |
| Net cash position 2021 | 1.09B 150M 12.49B | Net cash position 2022 | 566M 78.17M 6.52B | EV / Sales 2022 | 3.17 x |
| P/E ratio 2021 |
18.2
x | P/E ratio 2022 |
12.8
x | Employees | 2,508 |
| Yield 2021 |
1.7% | Yield 2022 |
2.72% | Free-Float | 52.62% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.44% | ||
| 1 week | +4.75% | ||
| Current month | -1.74% | ||
| 1 month | -2.69% | ||
| 3 months | -6.22% | ||
| 6 months | -19.36% | ||
| Current year | -17.82% |
1 week
8.39
9.08
1 month
8.149.50
Current year
7.4411.17
1 year
7.4414.39
3 years
7.4418.85
5 years
7.4423.69
10 years
7.4423.69
| Managers | Title | Age | Since |
|---|---|---|---|
En Ben Su
CEO | Chief Executive Officer | 58 | 08/02/08 |
Wen Ni
DFI | Director of Finance/CFO | 41 | 01/13/01 |
Gang Zhu
BRD | Director/Board Member | 38 | 01/12/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jing Luo
BRD | Director/Board Member | 62 | 16/22/16 |
En Ben Su
CEO | Chief Executive Officer | 58 | 08/02/08 |
Bin Yan
BRD | Director/Board Member | 42 | 01/10/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.07% | 12 M€ | -16.71% | - | |
| 0.00% | 117 M€ | +1.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 9.04 | +0.44% | 3,176,996 |
| 25/24/25 | 9 | +2.97% | 5,530,432 |
| 24/24/24 | 8.74 | +0.11% | 2,975,142 |
| 23/24/23 | 8.73 | +0.92% | 2,704,688 |
| 22/24/22 | 8.65 | +0.23% | 3,678,296 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Getein Biotech Inc is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and instruments. Its in vitro diagnostic reagents include Point-of-care Testing (POCT) reagents, chemiluminescence reagents, biochemical reagents, blood cell reagents, hemagglutination reagents and others. Its diagnostic instruments include immunoquantitative analyzer FIA 8000, immunoquantitative analyzer FIA 8600, fluorescence immunoquantitative analyzer Getein 1100, fluorescence immunoquantitative analyzer Getein 1180, automatic biochemical analyzer CM 400, automatic chemiluminescence analyzer MAGICL 6000 and five classification blood cell analyzer BHA-5000, among others. The Company also provides testing and agency services. The Company distributes its products within domestic market and to overseas markets.
Calendar
21/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -17.82% | 633M | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.29B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B |
- Stock Market
- Equities
- 603387 Stock
